SAN DIEGO -- (Business Wire)
Illumina, Inc. (NASDAQ:ILMN) today announced that it will webcast the
Company’s presentation at the Morgan Stanley Global Healthcare
Conference in New York on September 9, 2014. The live webcast is
scheduled to begin at 2:55 PM EDT and will feature a brief overview of
the company by Jay Flatley, Chief Executive Officer, followed by a
question and answer session.
The webcast can be accessed in the Investor Relations section of
Illumina's web site under the "Company" tab at www.illumina.com.
About Illumina
Illumina (www.illumina.com)
is a leading developer, manufacturer, and marketer of life science tools
and integrated systems for the analysis of genetic variation and
function. We provide innovative sequencing and array-based solutions for
genotyping, copy number variation analysis, methylation studies, gene
expression profiling, and low-multiplex analysis of DNA, RNA, and
protein. We also provide tools and services that are fueling advances in
consumer genomics and diagnostics. Our technology and products
accelerate genetic analysis research and its application, paving the way
for molecular medicine and ultimately transforming healthcare.
Contacts:
Illumina, Inc.
Investors:
Rebecca Chambers,
858-255-5243
rchambers@illumina.com
or
Media:
Jennifer
Temple, 858-882-6822
pr@illumina.com
Source: Illumina, Inc.
© 2024 Canjex Publishing Ltd. All rights reserved.